Immuneering Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Immuneering Corporation (IMRX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents36.1485.6772.6474.8937.09
Short-Term Investments0.0026.2632.8974.310.00
Cash & Short-Term Investments36.1485.67105.52149.2037.09
Accounts Receivable0.000.000.010.250.50
Inventory0.000.000.000.000.00
Other Current Assets3.440.703.212.890.14
Total Current Assets39.5989.08108.75152.3337.73
Non-Current Assets
Property, Plant & Equipment (Net)4.795.405.786.130.68
Long-Term Investments0.000.000.001.000.00
Goodwill6.696.696.696.700.00
Intangible Assets0.350.380.410.440.00
Other Non-Current Assets1.301.030.740.100.01
Total Non-Current Assets13.1313.5013.6214.370.00
Total Assets52.71102.58122.37166.7038.42
Current Liabilities
Accounts Payable1.967.293.151.391.48
Short-Term Debt0.340.000.000.000.00
Accrued Liabilities4.971.554.501.050.70
Other Current Liabilities0.230.260.020.000.00
Total Current Liabilities7.507.858.055.632.26
Non-Current Liabilities
Long-Term Debt3.824.164.465.090.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities3.824.164.465.090.00
Total Liabilities11.3312.0112.5210.722.80
Stockholders' Equity
Common Stock0.030.030.030.030.00
Retained Earnings-224.30-163.26-109.79-59.27-25.74
Accumulated Other Comprehensive Income0.000.00-0.03-0.050.00
Additional Paid-in Capital265.65253.81219.64215.280.00
Shares Outstanding31.0529.2726.4226.320.00
Total Stockholders' Equity41.3990.55109.85155.9835.62
Total Liabilities & Equity52.71102.58122.37166.700.00